Not left ventricular lead position, but the extent of immediate asynchrony reduction predicts long-term response to cardiac resynchronization therapy

被引:0
作者
Wolfram C. Poller
Henryk Dreger
Marius Schwerg
Hansjürgen Bondke
Christoph Melzer
机构
[1] Charité Universitätsmedizin Berlin,Medizinische Klinik mit Schwerpunkt Kardiologie und Angiologie (CCM)
来源
Clinical Research in Cardiology | 2014年 / 103卷
关键词
Cardiac resynchronization therapy; Asynchrony assessment; CRT super-responders; Left ventricular intramural delay; LV lead position;
D O I
暂无
中图分类号
学科分类号
摘要
Cardiac resynchronization therapy (CRT) is an effective treatment for a large subgroup of chronic heart failure patients. Various attempts to improve the high non-responder rate of 30 % by preoperative asynchrony assessment have failed. We hypothesized that superior response to CRT is correlated with greater acute reduction of asynchrony and that a concordant left ventricular (LV) lead is beneficial compared to a discordant lead. Hundred and eight consecutive CRT patients from our center were prospectively included. Clinical status and asynchrony parameters were assessed before, 1 day and 6 months after CRT implantation. Super-response was defined as an increase of the LV ejection fraction by ≥15 % and a decrease in LV end systolic volume (LVESV) by ≥30 %. When the criteria for super-response were not met, average response was given with a decrease of baseline LVESV ≥15 %. Sixty eight patients were classified as responders (63 %). Comparing super- (n = 19) and average (n = 49) responders, we found that greater acute reduction of LV asynchrony (change of asynchronous segments under CRT: −1.3 vs. −0.4, p < 0.05; decrease of LV intraventricular delay: −34 ms vs. −16 ms, p < 0.05) is associated with superior reverse remodeling after 6 months. Importantly, asynchrony parameters of super-, average and non-responders were almost identical at baseline. A concordant LV lead (n = 63) was not associated with improved LV reverse remodeling compared to a discordant lead (n = 28): LVEF: +8.6 % vs. +7.8 %, p = 0.91; LVESV: −30.5 ml vs. −23.8 mL, p = 0.84. A greater immediate reduction of LV asynchrony predicts superior response. Preoperative asynchrony parameters do not correlate with outcome. A concordant LV lead is not superior to a discordant lead.
引用
收藏
页码:457 / 466
页数:9
相关论文
共 119 条
[1]  
Abraham WT(2002)Cardiac resynchronization in chronic heart failure N Engl J Med 346 1845-1853
[2]  
Fisher WG(2004)Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure N Engl J Med 350 2140-2150
[3]  
Smith AL(2005)The effect of cardiac resynchronization on morbidity and mortality in heart failure N Engl J Med 352 1539-1549
[4]  
Bristow MR(2002)Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study J Am Coll Cardiol 40 111-118
[5]  
Saxon LA(2009)Cardiac-resynchronization therapy for the prevention of heart-failure events N Engl J Med 361 1329-1338
[6]  
Boehmer J(2007)European practice guidelines on cardiac pacemakers and cardiac resynchronization therapy. Working Group of the European Society of Cardiology (ESC) on cardiac pacemakers and cardiac resynchronization therapy. Developed in collaboration with the European Heart Rhythm Association Rev Esp Cardiol 60 1272.e1-1272.e51
[7]  
Cleland JG(2012)ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC Eur J Heart Fail 14 803-869
[8]  
Daubert JC(2008)Results of the Predictors of Response to CRT (PROSPECT) trial Circulation 117 2608-2616
[9]  
Erdmann E(2009)Effect of left ventricular lead concordance to the delayed contraction segment on echocardiographic and clinical outcomes after cardiac resynchronization therapy J Cardiovasc Electrophysiol 20 530-535
[10]  
Linde C(2012)Targeted left ventricular lead placement to guide cardiac resynchronization therapy: the TARGET study: a randomized, controlled trial J Am Coll Cardiol 59 1509-1518